IL2RA is an inclusion criterion in 3 clinical trials for hairy cell leukemia, of which 3 are open and 0 are closed. Of the trials that contain IL2RA status and hairy cell leukemia as inclusion criteria, 3 are phase 2 (3 open) [4].

IL2RA is an inclusion criterion in 1 clinical trial for primary cutaneous T-cell non-hodgkin lymphoma, of which 1 is open and 0 are closed. Of the trial that contains IL2RA status and primary cutaneous T-cell non-hodgkin lymphoma as inclusion criteria, 1 is phase 3 (1 open) [4].

IL2RA is an inclusion criterion in 1 clinical trial for sezary syndrome, of which 1 is open and 0 are closed. Of the trial that contains IL2RA status and sezary syndrome as inclusion criteria, 1 is phase 3 (1 open) [4].